The neuroendocrine immunology of rheumatoid arthritis

Bailliere's Clinical Rheumatology

Volumn 10, Issue 2, 1996, Pages 273-293

  Chikanza, I C ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; ARGININE; BETA ENDORPHIN; HYDROCORTISONE; PROLACTIN; SEX HORMONE; SUBSTANCE P; VASOPRESSIN;

ADRENAL FUNCTION; FEMALE; GENETICS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MALE; NEUROENDOCRINOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0029950918     PISSN: 09503579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3579(96)80018-5     Document Type: Article

References (114)

1. Adler GK, Smas CM, Fiandaca Met al (1990) Regulated expression of the human corticotropin releasing hormone by cAMP. Molecular Ceil Endocrinology 70: 165-174.
2. Akira S, Hirano T, Taga T & Kishimoto T (1990) Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB Journal 4: 2860-2867.
3. AI-Damluji S & Grossman A (1985) Adrenergic and opiod control of ACTH secretion in man. Neuroscience Letters 22: S406.
4. Al-Damluji S, Thomas R, White A & Besser M (1990) Vasopressin mediates alpha-l-adrenergic stimulation of adrenocorticotrophin secretion. Endocrinology 126: 1989-1995.
5. Antoni FA (1986) Hypothalamic control of ACTH secretion advances since the discovery of CRH. Endocrine Reviews 7: 351-379.
6. Arbiser JL, Morton CC, Bruns GA & Majzoub JA (1988) Human corticotropin releasing hormone gene is located on the long arm of chromosome 8. Cytogenetics and Cell Genetics 47:113-116.
7. Bacon PA & Kitas GD (1994) The significance of vascular inflammation in rheumatoid arthritis. Annals of Rheumatic Diseases 53: 621-623.
8. Bertoglio JH & Leroux E (1988) Differential effects of glucocorticosteroids on the proliferation of a murime helper and cytotoxic cell clone in response to IL-2 and IL-4. Journal of Immunology 141: 1191-1196.
9. Beyer HS, Matta SG & Sharp BM (1988) Regulation of mRNA of CRH in the paraventricular nucleus and other brain sites of the rat. Endocrinology 123:2117-2122.
10. Blatteis CM, Xin L & Quan N (1994) Neuromodulation of fever: a possible role for substance P. Annals of the New York Academy of Science 741: 162-172.
11. Boki KA, Panayi GS, Vaughan RW et al (1992) HLA class 2 sequence polymorphism and susceptibility to rheumatoid arthritis in Greeks. Arthritis and Rheumatism 35: 749-755.
12. Boki KA, Drosos A, Tzioufas A et al (1993) Examination of HLA DR4 as a severity marker for rheumatoid arthritis in Greek patients. Annals of Rheumatic Diseases 52" 517-519.
13. Bums G, Almeida OFX, Passarelli F & Herz A (1989) A two step mechanism by which CRH releases hypothalamic 13-endorphiu: the role of vasopressin and G proteins. Endocrinology 125:1365-1371.
14. Calogero AE, Sternberg EM, Bagdy Get al (1992) Neurotransmitter-induced hypothalamicpituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. Neuroendocrinology 55: 600-608.
15. Carter DB, Deibel MR, Dunn CJ et al (1990) Purification, cloning, expression and biological activity of an interleukin-1 receptor antagonist. Nature 344: 633-638.
16. Cash JM, Crofford L J, Galluci WT et al (1992) Pituitary-adrenal axis responsiveness to ovine corticotropin releasing hormone in patients with rheumatoid arthritis treated with low dose prednisone. Journal of Rheumatology 19: 1692-1696.
17. Chikanza IC (1991) New insights: Auto-immunity and connective tissue diseases. Central African Journal of Medicine 37: 427-433.
18. Chikanza IC (1995) The hypothalamic-pituitary adrenal effects of non-steroidal anti-inflammatory drugs. Arthritis and Rheumatism 38: 723-724.
19. Chikanza IC & Panayi GS (1991) Hypothalamic-pituitary mediated modulation of immune function: Prolactin is a neuroimmune peptide. British Journal of Rheumatology 30: 203-207.
20. Chikanza IC & Panayi GS (1993) The effects of hydrocortisone on in vitro lymphocyte proliferation and interleukin-2 and-4 production in corticosteroid sensitive and resistant subjects. European Journal of Clinical Investigations 23: 845-850.
21. Chikanza IC, Chrousos G & Panayi GS (1992b) Abnormal neuroendocrine immune communications in rheumatoid arthritis. European Journal of Clinical Investigations 22: 635-637.
22. Chikanza IC, Roux-Lombard P, Dayer J-M & Panayi GS (1993b) TNF soluble receptors (TNF inhibitors) behave as acute phase proteins following major surgery in patients with rheumatoid arthritis, osteomyelitis and osteoarthritis. Clinical Experimental Immunology 92" 19-22.
23. Chikanza IC, Petrou P, Panayi GS & Chrousos GP (1995a) Arginine vasopressin secretion in rheumatoid arthritis: pathophysiological implications. Arthritis and Rheumatism 38: S216.
24. Chikanza IC, Roux-Lombard P, Dayer J-M & Panayi GS (1995b) Dysregulated interleukin-1 receptor antagonist protein production in rheumatoid arthritis; pathogenetic implications. Arhtritis and Rheumatism 38: 642-648.
25. Chikanza IC, Petrou P, Kingsley Get al (1992a) Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis and Rheumatism 35: 1281-1288.
26. Chikanza IC, Cutbush S, Biro A et al (1993a) HLA DRB allelic variation and rheumatoid arthritis in Zimbabwe. British Journal of Rheumatology 31 (supplement 2): 8.
27. Chikanza IC, Petrou P, Chrousos Get al (1993c) Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implications. British Journal of Rheumatology 32: 445-448.
28. Chowdrey HS, Lessop DS & Lightman SL (1990) Substance P stimulates AVP and inhibits ACTH release in vivo in the rat. Neuroendocrinology 52: 90-93.
29. Colville-Nash PR & Scott DL (1992) Angiogenesis and rheumatoid arthritis: pathogenetic and therapeutic implicaions. Annals of Rheumatic Disesases 50: 124-132.
30. Costa A, Trainer T, Besser GM & Grossman A (1993) Nitric oxide modulates the release of corticotropin releasing hormone from the rat hypothalamus. Brain Research 605: 187-192.
31. Crofford C, Sano H, Karalis K et al (1993) Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. Journal of Immunology 151:1587-1596.
32. Cutolo M & Accuado S (1991) Sex hormones, HLA and rheumatoid arthritis. Clinical Experimental Rheamatology 9: 641-646.
33. Cutolo M, Sulli A, Barone A et al (1995) The role of androgens in the pathophysiology of rheumatoid arthritis. Fundamental and Clinical Immunology 3: 9-18.
34. Daynes RA & Araneo BA (1989) Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors IL-2 and IL-4. European Journal of Immunology 19: 2319-2325.
35. Dougados M, Duchesne L & Amor B (1988) Bromocriptine and cyclosporin A combination therapy in rheumatoid arthritis. Arthritis and Rheumatism 31:1333-1334 (letter).
36. Edmonds SE, Blake DR, Morris CJ & Winyard PG (1993) An imaginative approach to synovitis-the role of hypoxic reperfusion damage in arthritis. Journal of Rheumatology 20 (supplement 37): 26-31.
37. Ferrari C, Mattei A, Melis GB et al (1989) Cabergoline: long-acting oral treatment of hyperprolactinemic disorders. Journal of Clinical Endocrinology and Metabolism 68: 1201-1206.
38. Firestein GS (1994) Rheumatoid synovitis and pannus. In Klippel JA & Dieppe PA (eds) Rheumatology, pp 12.1-12.30. St. Louis: CV Mosby.
39. Firestein GS & Zvaifler NH (1990) How important are T cells in chronic rheumatoid synovitis. Arthritis and Rheumatism 33: 768-772.
40. Fischer E, van Zee K J, Marano MA et al (1990) Interleukin-1 receptor antagonist circulates in experimental inflammation and human disease. Blood 79: 2192-2200.
41. Fitzpatrick F, Christeff N, Durant S et al (1992) Glucortieoids in the non-obese (NOD) mouse: basal serum levels, effect of endocrine manipulation and immobilization stress. Life Science 50:1063-1069.
42. Folkman J & Ingber DE (1987) Angiostatie steroids: method of discovery and mechanism of action. Annals of Surgery 206: 374-382.
43. Futaka J, Tsukada T, Nakai Yet al (1990) Effects of repetitive administration of CRH combined with lysine vasopressin on plasma ACTH and cortisol in secondary adrenal insuffciency. Journal of Clinical Endocrinology and Metabolism 1" 1624-1631.
44. Ganapathi MK, Rzewnicki D, Samols D et al (1991) Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B ceils. Journal of Immunology 147: 1261-1265.
45. Garcia I, Perez Castillo A, Moreno & Alemany C (1992) β-endorphin inhibits IL-2 release and expression of IL-2 receptor in conA stimulated splenic lymphocytes. Lymphocyte Cytokine Research 11: 339-345.
46. Gerencer M, Tajic M, Kehin-Brkljacic V & Kastelan A (1982) An association between serum testosterone level and HLA phenotype. Immunology Letters 4: 155-158.
47. German T, Gately MF, Schoenhaunt DS et al (1993) Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on Thl but not Th2 cells. European Journal of Immunology 23:1762-1770.
48. Gillies GE, Linton EA & Lowry PJ (1982) Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299: 355-357.
49. Goland RS, Wardlaw SL, McCarter et al (1991) Adrenocorticotropin and cortisol responses to vasopressin during pregnancy. Journal of Clinical Endocrinology and Metabolism 3: 257-261.
50. Gregersen PK, Silver J & Winchester RJ (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis and Rheumatism 30: 1205-1213.
51. Guillon G, Trueba M, Joubert D et al (1995) Vasopressin stimulates steroid secertion in human adrenal glands: comparison with angiotensin 2 effect. Endocrinology 136: 1285-1295.
52. Halko G, Arrows S, Affeck G & Waterman J (1995) Serum prolactin levels and disease activity in RA. Arthritis and Rheumatism 38: S289.
53. Hall J, Morand EF, Edbak Set al (1994) Abnormal hypothalamic pituitary adrenal axis function in RA. Arthritis and Rheumatism 37: 1132-1137.
54. Harbuz MS, Leonard JP, Lightman SL et al (1993) Changes in hypothalamic corticotrophin releaseing factor and pituitary POMC mRNA during the course of experimental allergic encephalomyelitis. Journal of Neurendocrinology 45" 127-132.
55. Hench PS (1938) The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrathrosis. Mayo Clinic Proceedings 13: 161-167.
56. Hernanz A, Miguel E, Romera Net al (1993) Calcitonin gene related peptide, substance P and VIP in the plasma and synovial fluid of patients with inflammatory joint disease. British Journal of Rheumatology 32: 31-35.
57. Hillhouse EW & Milton NGN (1989) Effect of noradrenaline and gamma-aminobutyric acid on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro. Journal of Endocrinology 122: 719-723.
58. Jarvinen P & Aho K (1994) Twin studies in rheumatic diseases. Seminars in Arthritis and Rheumatism 24: 19-28.
59. Jorgensen C, Bressot N, Bologna C & Sany J (1995) Dysregulation of hypothalamo-pituitary axis in rheumatoid arthritis. Journal of Rheumatology (in press).
60. Karalis K, Sano H, Redwine Jet al (1990) Inflammatory disease suceptible Lewis rats: evidence for central deficiency but peripheral excess of CRH synthesis/secretion. Pediatric Research 29: 80A.
61. Katsikis PD, Chu C-Q, Brennan FM et al (1994) Immuuoregulatory role of interleukin 10 in rheumatoid arthritis. Journal of Experimental Medicine 179: 1517-1527.
62. Kovacs KJ & Mezey E (1987) Dexamethasone inhibits corticotropin releasing factor gene expression inthe rat paraventricular nucleus. Neuroendocrinology 46: 365-368.
63. Leijon K, Hammarstrom B & Holmberg D (1994) Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells. International Immunology 6:339-345.
64. Levick JR (1990) Hypoxia and acidosis in chronic inflammatory arthritis; Relation to vascular supply and dynamic effusion pressure. Journal of Rheumatology 17: 579-582.
65. Mackiewicz A, Schooltink H, Heinrich PC & Rose-John S (1992) Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute phase proteins. Journal of Immunology 146:2021-2029.
66. Marguerie C, David J, So AK & Walport MJ (1990) A pilot study comparing bromocriptine with d-penicillamine in the treatment of rheumatoid arthritis. British Journal of Rheumatology 29 (supplement 2): 3.
67. Masi AT (1994) Incidence of rheumatoid arthritis: Do the observed age-sex interaction patterns support a role of androgenic-anabolic (AA) steroid deficiency in its pathogenesis? British Journal of Rheumatology 33: 697-699.
68. Masi AT, Feigenbaum SL, Chatterton RT et al (I 995) Integrated hormonal-immunological-vascular ('H-I-V' triad) systems interactions in rheumatic diseases. Clinical and Experimental Rheumatology 13: 203-216.
69. Mason D, Macphee I & Antoni F (1990) The role of the neuroendocrine system in determining susceptibility to experimental allergic encephalomyelitis in the rat. Immunology 70: 1-5.
70. Miossec P, Briolay J, Dechanet J et al (1992) Inhibition of the production of pro-inflammatory cytokines and immunoglobins by IL-4 in an ex-vivo model of rheumatoid synovitis. Arthritis and Rheumatism 35" 874-883.
71. Morita u Yamamura M, Harada Set al (1995) Anti-inflammatory properties of interleukin-13 in rheumatoid synovial inflammation. Arthritis and Rheumatism 38: S353.
72. Neeck G, Federlin K, Graef Vet al (1990). Adrenal secretion of cortisol in patients with rheumatoid arthritis. Journal of Rheumatology 17: 24-29.
73. Nelson JL, Hughes KA, Smith AG et al (1993) Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced ameliorization of rheumatoid arthritis. New England Journal of Medicine 329:466-471.
74. Patchev VK, Kalogeras L J, Zelazowski Pet al (1992). Increased plasma concentrations, hypothalamic content, and in vitro release of arginine-vasopressin in inflammatory disease-prone, hypothalamic CRH-deficient Lewis rats. Endocrinology 131: 1453-1457.
75. Patchev VK, Matorakos G, Brady LS et al (1993) Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats of inflammatory disease. Neuroendocrinology 58:106-110.
76. Peers SH, Duncan GS, Flower RJ & Boulton C (1995) Endogenous corticosteroids modulate lymphoproliferation and susceptibility to experimental allergic encephalomyelitis in the Brown Norway rat. International Archives of Allergy and Immunology 106: 20-28.
77. Perrandin V, Delarue C, Lefevre H et al (1993) Vasopressin stimulates cortisol secretion from human adrenal tissue through activation of Vi receptors. Journal of Clinical Endocrinology and Metabolism 76: 1522-1528.
78. Risdon G, Cope J & Bennet M (1990) Mechanisms of chemoprevention by dietary DHEA: inhibition of lymphopoiesis. American Journal of Pathology 136: 759-769.
79. Rivier C (1995) Blocking of nitric oxide production by blood-borne IL-1 β: role of AVE prostaglandins and αl-adrenergic receptors. Endocrinology 136: 3597-3603.
80. Rivier C & Vale W (1983) Interaction of corticotropin-releasing factor and arginine vasopressin on ACTH secretion in vivo. Endocrinology 113: 939-942.
81. Roche PJ, Crawford R J, Fernley RT et al (1988) Nucleated sequence of the gene coding for ovine corticotropin-releasing factor and regulation of its mRNA levels by ghicocorticoids. Gene 71: 421-431.
82. Romagnani S (1991) Human Thl and Th2 subsets: doubt no more. Immunology Today 12: 256-257.
83. Rook GAW, Hernandez-Pando R & Lightman SL (1994) Hormones, peripherally activated prohormones and regulation of the Thl/Th2/balance. Immunology Today 15: 301-303.
84. Rothschild B & Masi AT (1982) Pathogenesis of rheumatoid arthritis: A vascular hypothesis. Seminars in Arthritis and Rheumatism 12:11-31.
85. Saldanha C, Tougas G & Grace E (1986) Evidence for anti-inflammatory effect of normal circulating plasma cortisol. Clinical and Experimental Rheumatology 4: 365-366.
86. Salgame P, Abrams JS, Clayberger C et al (1991) Differing lymphokine profile of functional subsets of human CD4 and CD8 T cell clones. Science 254: 279-289.
87. Shibahara S, Morimoto Y, Furutani Yet al (1983) Isolation and sequence analysis of human CRF gene. EMBO Journal 2: 775-778.
88. Silman AJ (1992) The genetic epidemiology of rheumatoid arhtritis. Clinical Experimental Rheumatology 10: 309-312.
89. Stastry P (1978) Association of B cell alloantigen Drw4 with rheumatoid arthritis. New England Journal of Medicine 298: 869-871.
90. Sternberg EM, Hill JM, Chrousos GP et al (1989a) Inflammatory mediator-induced hypothalamie-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis susceptible Lewis rats. Proceedings of the National Academy of Science, USA 86: 2374-2378.
91. Sternberg EM, Young WS, Bernardini R et al (1989b) A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wallinduced arthritis in Lewis rats. Proceedings of the National Academy of Science, USA 86:4771-4775.
92. Stevens CR, Blake DR, Merry Pet al (1991) A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis and Rheumatism 34: 1508-1513.
93. Suda T, Tozawa F, Ushiyama T et al (1990) Interleukin-I stimulates corticotropin-releasing factor gene expression in rat hypothalamus. Endocrinology 126: 1223-1228.
94. Sweep F, Rijnkels C & Hermus A (1991) Activation of the hypothalamus-pituitary-adrenal axis by cytokines. Acta Endocrinology (Copenhagen) 125 (supplement 1): 84-91.
95. Thompson RC, Seasholtz AF & Herbert E (1987) Rat corticotropiu- releasing hormone geue: sequence and tissue specific expression. Molecular Endocrinology 1: 363-370.
96. Tsagarakis S, Navara P, Rees LH et al (1989) Morphine directly modulates the release of stimulated CRF-41 from rat hypothalamus in vitro. Endocrinology 124: 2330-2335.
97. Tsagarakis S, Holly JMP, Rees LH et al (1988) Acetylcholine and norepinephrine stimulate CRF-41 release from the rat hypothalamus in vitro, Endocrinology 123: 1962-1969.
98. Udelsman R & Chrousos GP (1988) Hormonal responses to surgical stress. In Chrousos GP, Loriaux DL & Lipsett MB (eds) Advances in Experimental Medicine and Biology, pp 265-272. New York: Plenum Press.
99. Vamvakopoulos NC & Chrousos GP (1993) Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction. Journal of Clinical Investigations 92: 1896-1902.
100. Vamvakopoulos NC, Karl M, Mayol Vet al (1990) Structural analysis of the regulatory region of the human corticotropin releasing hormone gene. FEBS Letters 267: 1-5.
101. Van LP, Spengler DH & Holsboer F (1990) Glucocorticoid repression of 3', 5' cyclic adenosine monophosphate dependent human corticotropin releasing hormone gene promoter activity in a transfected mouse anterior pituitary cell line. Endocrinology 127: 1412-1418.
102. van der Bergh R Rozing J & Nagelkerken L (1993) β-endorphin stimulates Ia expression on mouse cells by inducing IL-4 secretion by CD4+ T cells. Cell Immunology 149:180-192.
103. Varani J, Mulligan MS & Ward PS (1994) The vascular endothelium and acute inflammation. In Klippel JA & Dieppe PA (eds) RheumatoIogy, pp 11.1-12.0. St. Louis: CV Mosby.
104. Weyand CM & Goronzy JJ (1994) Disease mechanisms in rheumatoid arthritis: Gene dosage effect of HLA-DR haplotypes. Journal of Laboratory and Clinical Medicine 124: 335-338.
105. Weyand CM, Hicok KC, Conn DL et al (1992) The influence of HLA-DRB1 genes on disease severity. Annals of Internal Medicine 117: 801-806.
106. Wick G, Hu Y, Gruber Jet al (1993) The role of modulatory factors in the multifaceted pathogenesis of autoimruune thyroiditis. International Reviews of Immunology 9: 77-89.
107. Wilder R, Calandra GB, Garvin AJ et al (1982) Strain and sex variation in the susceptibility to streptococcal cell wall induced arthritis in rats. Arthritis and Rheumatism 25: 1064-1072.
108. Wilder R, Allen JB, Wahl LM et al (1983) The pathogenesis of group A streptococcal cell wall induced polyarthritis in rat. Arthritis and Rheumatism 26: 442-451.
109. Williams DG (1994) Autoimmunity in rheumatoid arthritis. In Klippel JA & Dieppe PA (eds) Rheumatology, pp 9.1-9.14. St. Louis: CV Mosby.
110. Wittert GA, Donald RA, Gilford EJ et al (1990) Arginine vasopressin in Cushings disease. Lancet 335: 991-994.
111. Wordsworth P (1990) The imrnunogenetics of RA. Current Opinions in Rheumatology 2: 423-429.
112. Wu CY, Fargeas C, Nakajima T & Delespesse G (1991) Glucocorticoids suppress the production of IL-4 by human lymphocytes. European Journal of Immunology 21: 2645-2647.
113. Yelamos J, Garcia-Lozuno JR, Moreno I et al (1993) Association of HLA DR4 and DR10 with rheumatoid arthritis in a Spanish population. Arthritis and Rheumatism 36:811-813.
114. Yssel H, Malefye RDW, Roncaroto MG et al (1992) IL-10 is produced by subsets of human CD4+T cell clones and peripheral blood cells. Journal oflmmunology 149: 2378-2384.